I-Mab Appoints Dr. Sean Fu as Permanent CEO
Ticker: NBP · Form: 6-K · Filed: Nov 6, 2024 · CIK: 1778016
Sentiment: neutral
Topics: executive-appointment, management-change
TL;DR
I-Mab makes interim CEO Sean Fu permanent, effective Nov 1st.
AI Summary
I-Mab announced on November 6, 2024, the appointment of Dr. Sean Xi-Yong Fu as its permanent Chief Executive Officer, effective November 1, 2024. Dr. Fu had previously been serving in this role on an interim basis. This appointment formalizes his leadership position within the company.
Why It Matters
The permanent appointment of a CEO signals leadership stability and a clear direction for the company's strategic initiatives and future operations.
Risk Assessment
Risk Level: low — This filing is a routine announcement of an executive appointment and does not involve significant financial or operational changes.
Key Players & Entities
- I-Mab (company) — The company making the announcement.
- Dr. Sean Xi-Yong Fu (person) — Appointed as permanent Chief Executive Officer.
- November 1, 2024 (date) — Effective date of the CEO appointment.
- November 2024 (date) — Reporting period for the Form 6-K.
FAQ
Who has been appointed as the permanent Chief Executive Officer of I-Mab?
Dr. Sean Xi-Yong Fu has been appointed as the permanent Chief Executive Officer of I-Mab.
When did Dr. Sean Xi-Yong Fu's appointment as permanent CEO become effective?
The appointment became effective on November 1, 2024.
What type of filing is this announcement from I-Mab?
This announcement is made via a Form 6-K filing.
Was Dr. Fu previously in a leadership role at I-Mab?
Yes, Dr. Fu had been serving as interim CEO prior to his permanent appointment.
What is the principal executive office address for I-Mab?
The principal executive offices are located at 2440 Research Boulevard, Suite 400, Rockville, MD 20850.
Filing Stats: 458 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-11-06 07:00:02
Filing Documents
- sean_fu_ceo_appt_11.6.20.htm (6-K) — 24KB
- imab-ex99_1.htm (EX-99.1) — 14KB
- 0000950170-24-121803.txt ( ) — 39KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. I-MAB By : /s/ Joseph Skelton Name : Joseph Skelton Title : Chief Financial Officer Date: November 6, 2024